Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

55.04
+1.102.03%
Post-market: 55.040.00000.00%19:30 EDT
Volume:33.64K
Turnover:1.85M
Market Cap:192.64M
PE:- -
High:55.51
Open:54.50
Low:54.37
Close:53.95
52wk High:70.85
52wk Low:40.40
Shares:3.50M
Float Shares:3.50M
Volume Ratio:0.55
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Xenon Stock Craters on Drug Trial Setback. Its Failure Could be This Rival's Gain.

Dow Jones
·
Sep 18

A Sideways Market and Rising Earnings Are Presenting Opportunities Not Seen Since ChatGPT First Launched

Dow Jones
·
Sep 18

【US Pre-Market】US Stock Futures Mixed on Triple Witching; Optical Communication, Storage, and Crypto Stocks Gain as WTI Crude Plunges Over 5%

TradingKey
·
Sep 18

Top Premarket Decliners

MT Newswires Live
·
Sep 18

U.S. Stocks on the MOVE-Netflix, Etsy, Viant Technology

Reuters
·
Sep 18

Xenon Stock Faces Worst Day Since 2017 as Lead Drug Proves a Double-Edged Sword

Dow Jones
·
Sep 18

Xenon Pharmaceuticals Inc. : Deutsche Bank Cuts to Hold from Buy; Cuts Target Price to $46 from $90

THOMSON REUTERS
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)

TIPRANKS
·
Sep 18

Xenon Pharmaceuticals Shares Fall 27,5% Premarket After Co Pauses New Enrollment in Depression Drug Trials

THOMSON REUTERS
·
Sep 18

Xenon Pharmaceuticals Inc. : RBC Cuts Target Price to $70 from $81

THOMSON REUTERS
·
Sep 18

Stocks to Watch: Xenon Pharmaceuticals, Ultragenyx Pharmaceutical, BRT Apartments

Dow Jones
·
Sep 18

CG Oncology Director Leonard E. Post Disposes of 1,000 Common Shares Worth $72,980

Reuters
·
Sep 18

Xenon Pharma Plunges After Pausing Trial Enrollment Due to Side Effects

Reuters
·
Sep 18

Xenon Submits FDA NDA for Azetukalner in Focal Seizures

Reuters
·
Sep 18

Xenon Pharmaceuticals - Initiates Temporary Pause of Enrollment in Ongoing Psychiatry Studies

THOMSON REUTERS
·
Sep 18

Xenon Announces Azetukalner Nda Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

THOMSON REUTERS
·
Sep 18

Xenon Pharmaceuticals - Enrollment in X-Nova2 Study in Mdd Completed; Topline Data Expected Q1 2027

THOMSON REUTERS
·
Sep 18

Xenon Pharmaceuticals Inc: Voluntary Action Does not Impact Ongoing Epilepsy Studies

THOMSON REUTERS
·
Sep 18

Biohaven Stock is Sinking. Epilepsy Drug Trial Roadblock is Only the Latest Blow.

Dow Jones
·
Sep 11

Structure weakness ‘disconnected’ from underlying data, says Jefferies

TIPRANKS
·
Sep 09